HK1096670A1 - Pyrrolo-pyrazine derivatives useful as cb1-modulators - Google Patents
Pyrrolo-pyrazine derivatives useful as cb1-modulatorsInfo
- Publication number
- HK1096670A1 HK1096670A1 HK07101236A HK07101236A HK1096670A1 HK 1096670 A1 HK1096670 A1 HK 1096670A1 HK 07101236 A HK07101236 A HK 07101236A HK 07101236 A HK07101236 A HK 07101236A HK 1096670 A1 HK1096670 A1 HK 1096670A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- sup
- alkyl group
- mono
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0327331.5A GB0327331D0 (en) | 2003-11-25 | 2003-11-25 | Therapeutic agents |
PCT/GB2004/004934 WO2005051953A2 (en) | 2003-11-25 | 2004-11-24 | Pyrrolo-pyrazine derivatives useful as cb1-modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1096670A1 true HK1096670A1 (en) | 2007-06-08 |
Family
ID=29797731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07101236A HK1096670A1 (en) | 2003-11-25 | 2007-02-01 | Pyrrolo-pyrazine derivatives useful as cb1-modulators |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070099923A1 (xx) |
EP (1) | EP1701958B1 (xx) |
JP (1) | JP2007512298A (xx) |
CN (1) | CN1886405A (xx) |
AT (1) | ATE361301T1 (xx) |
AU (1) | AU2004292493B2 (xx) |
CA (1) | CA2546318A1 (xx) |
DE (1) | DE602004006313T2 (xx) |
ES (1) | ES2285544T3 (xx) |
GB (1) | GB0327331D0 (xx) |
HK (1) | HK1096670A1 (xx) |
WO (1) | WO2005051953A2 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101686644B (zh) * | 2007-06-29 | 2014-03-26 | 韦尔豪泽公司 | 通过早期单个分离针叶树体细胞胚增加萌发势的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
DZ3335A1 (fr) * | 2000-03-23 | 2001-09-27 | Solvay Pharm Bv | Derives de 4,5-dihydro-1h-pyrazole ayant une activite antagoniste de cb1 |
SE0104330D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0302673D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
-
2003
- 2003-11-25 GB GBGB0327331.5A patent/GB0327331D0/en not_active Ceased
-
2004
- 2004-11-24 DE DE602004006313T patent/DE602004006313T2/de not_active Expired - Fee Related
- 2004-11-24 CN CNA2004800348029A patent/CN1886405A/zh active Pending
- 2004-11-24 AT AT04798641T patent/ATE361301T1/de not_active IP Right Cessation
- 2004-11-24 AU AU2004292493A patent/AU2004292493B2/en not_active Ceased
- 2004-11-24 EP EP04798641A patent/EP1701958B1/en active Active
- 2004-11-24 ES ES04798641T patent/ES2285544T3/es active Active
- 2004-11-24 CA CA002546318A patent/CA2546318A1/en not_active Abandoned
- 2004-11-24 JP JP2006540602A patent/JP2007512298A/ja not_active Withdrawn
- 2004-11-24 US US10/579,830 patent/US20070099923A1/en not_active Abandoned
- 2004-11-24 WO PCT/GB2004/004934 patent/WO2005051953A2/en active IP Right Grant
-
2007
- 2007-02-01 HK HK07101236A patent/HK1096670A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1886405A (zh) | 2006-12-27 |
ATE361301T1 (de) | 2007-05-15 |
WO2005051953A2 (en) | 2005-06-09 |
DE602004006313D1 (de) | 2007-06-14 |
AU2004292493B2 (en) | 2008-01-24 |
JP2007512298A (ja) | 2007-05-17 |
GB0327331D0 (en) | 2003-12-31 |
US20070099923A1 (en) | 2007-05-03 |
ES2285544T3 (es) | 2007-11-16 |
CA2546318A1 (en) | 2005-06-09 |
DE602004006313T2 (de) | 2008-01-10 |
WO2005051953A3 (en) | 2005-07-28 |
AU2004292493A1 (en) | 2005-06-09 |
EP1701958A2 (en) | 2006-09-20 |
EP1701958B1 (en) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104330D0 (sv) | Therapeutic agents | |
TW200503692A (en) | Therapeutic agents | |
HUP0401538A2 (hu) | Új, helyettesített aminometilcsoportot tartalmazó N-(arilszulfonil)-béta-aminosav-származékok, előállításukra alkalmas eljárás és a vegyületeket tartalmazó gyógyászati készítmények | |
AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
AP1860A (en) | Aryl fused azapolycyclic compounds. | |
NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
TNSN05252A1 (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders : process for their preparation and pharmaceutical compositions containing them | |
EP1725536B8 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
NO20051225L (no) | 1,2,4- oksadiazoler som modulatorer av metabotropisk glutamat-reseptor-5 | |
WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
PL1625126T3 (pl) | Imidazo- i tiazolopirydyny jako inhibitory kinazy JAK3 | |
HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
WO2005056535A8 (en) | 1,2,3-triazole amide derivatives as inhibitors of cytokine production | |
EP1798216A4 (en) | INTERMEDIATE PRODUCT OF A 6-SUBSTITUTED 1-METHYL-1H-BENZIMIDAZOLE DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF | |
NO20076000L (no) | Aminosyrederivater | |
BR0318521A (pt) | arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados | |
HK1096670A1 (en) | Pyrrolo-pyrazine derivatives useful as cb1-modulators | |
SG146627A1 (en) | Imidazole derivatives | |
DE60226971D1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
TW200604181A (en) | 2h- or 3h-benzo[e]indazol-1-yl carbamate derivatives, their preparation and their application in therapeutics | |
DK1373218T3 (da) | Imidazolylderivater til anvendelse som histamin H3-receptorligander | |
WO2005007630A3 (en) | Aryl fused azapolycyclic compounds | |
UA84737C2 (ru) | Производные имидазолина с антагонистической активностью относительно cb1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20101124 |